article thumbnail

Tapping the potential applications of mHealth

The Health Policy Exchange

One popular mHealth initiative is the text4baby program, a public-private partnership launched in 2010 that sends free text messages to expectant and new mothers containing appointment reminders, safety alerts, and general prenatal and postpartum health advice. and abroad was the topic of a recent Georgetown University Health Policy Seminar.

article thumbnail

The Massachusetts Avenue of health reform

The Health Policy Exchange

Personal responsibility was important, some aides argued, but what about the libertarian view that the government had no business requiring people to buy something? in 2010, as the national average rose from 15.2% It was one thing to ask drivers to buy car insurance. Owning a car is a choice. in 2006 to 1.9% Phillips, Jr.

Insurance 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Green Practice News: May 2025

My Green Doctor

For instance, the UK government’s initiative to install solar panels on National Health Service sites is projected to save each site up to £45,000 annually, amounting to approximately £13 million in total savings per year. Eye 24 , 361–363 (2010). Let’s build a future where healthcare not only heals—it leads. 3 “Each U.S.

article thumbnail

Here It Goes, Here It Goes, Here It Goes Again: The Build Back Better Act (Redux)

FDA Law

If the biosimilar has not been licensed and marketed within the approved delay period (either 1 or 2 years depending on likelihood of licensure), the manufacturer of the biological product must pay a rebate to the government for the lost savings due to the delay. Koblitz & Kurt R. Each product is limited to two years of delay.

IT 52
article thumbnail

D.C. Circuit Sides with Manufacturers in Latest 340B Contract Pharmacy Case

FDA Law

In 2010, the Health Resources and Services Administration (HRSA) authorized covered entities to contract with an unlimited number of retail pharmacies to fill prescriptions for their patients. District Court and won, prompting a government appeal to the D.C. Novartis and United Therapeutics Corporation sued in the D.C.

article thumbnail

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law

Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not. A 2018 report by the Government Accountability Office (“GAO”) found similar issues, as well as contract pharmacy noncompliance and poor federal oversight.

article thumbnail

The Good, the Bad and the Ugly: New FDA Legislative Proposal on 180-Day Exclusivity (Both “the Bad” and “the Ugly”)

FDA Law

FDA from January 2010 to June 2017 ” as evidence to support the premise above. Karst — It was some time ago that we posted on what we though was “the Good” in an avalanche of FDA-related legislation that we sorted into three categories: the Good, the Bad, and the Ugly. things too—come to those who wait! It’s regime change!